Omixon Academy 2020 – HLA (Human Leukocyte Antigen) and its Basic Immunological Roles

During the COVID-19 pandemic, Omixon is committed to continuously provide resources and educational material to the HLA community. We have compiled a list of topics that both beginners and advanced users could find beneficial. This time, Omixon invites you to join our next educational session to learn more about HLA (Human Leukocyte...

 

Read more

Omixon Founder, Attila Bérces Returns as CEO, Aims to Roll-Out New Products

We are happy to announce that Omixon’s founder and chairman Dr. Attila Bérces returns as CEO. Outgoing CEO Dr. Peter Meintjes led the early commercialization of Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role in 2017. In concert between the incoming and outgoing CEOs, as...

 

Read more

Webinar – HLA Typing Uses in Research. How is HLA Explore Used to Facilitate it?

Join us for a Webinar on Tuesday, April 7 with Efi Melista (Head of Product, Omixon) who will be talking about the uses of HLA typing in research and population studies, and how Omixon’s HLA Explore can facilitate it. Examples in disease associations, pharmacogenetics, drug sensitivities and overall population genetics...

 

Read more

Do You Know What it Takes to CE Mark an HLA Typing Product?

Abstract presentation by Omixon’s Senior Technical Lead Assay R&D, Dr. Gergely Tölgyesi, from the latest 14th East-West Immunogenetics Conference (Budapest, Hungary). Abstract: European transplantation laboratories require the use of CE-marked HLA typing products for diagnostic purposes. The CE mark (“Conformité Européenne”, French for European conformity) is a symbol that a...

 

Read more